- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BRAF
Total 537 results
-
Philip FriedlanderGenentech, Inc.TerminatedMelanomaUnited States
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid TumorsUnited States, Spain, Canada, Norway, Switzerland
-
Kiang Wu HospitalCompleted
-
Fudan UniversityUnknownColorectal Cancer | Liver Metastases
-
University of California, San FranciscoNovartisCompletedBRAF Mutant Metastatic MelanomaUnited States
-
Hanmi Pharmaceutical Company LimitedCompletedSolid TumorKorea, Republic of
-
Gruppo Oncologico Italiano di Ricerca ClinicaUnknown
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Melanoma | Stage IV MelanomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Genentech, Inc.Completed
-
Asana BioSciencesCompletedCancer | Neoplasm Metastasis | Pancreatic Cancer | Metastatic Cancer | Metastatic Lung Cancer | Pancreas Adenocarcinoma | Metastatic Melanoma | Colon Cancer | Colonic Neoplasms | Pancreas Cancer | Non Small Cell Lung Cancer Metastatic | Neoplasm | Pancreas Neoplasm | Metastatic Pancreatic Cancer | Metastatic Colon Cancer and other conditionsUnited States
-
AstraZenecaApproved for marketingRelapsed/Refractory Hairy Cell Leukemia
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterCompletedSolid Tumor | Advanced CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Daiichi Sankyo, Inc.PlexxikonTerminatedV600-mutated BRAF Unresectable Melanoma | V600-mutated BRAF Metastatic Melanoma | Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF InhibitorUnited States, Germany, France
-
Memorial Sloan Kettering Cancer CenterNovartis; National Comprehensive Cancer NetworkCompleted
-
NYU Langone HealthCelldex TherapeuticsTerminated
-
Gruppo Oncologico del Nord-OvestUnknownElderly Metastatic Colorectal Cancer PatientsItaly
-
Inge Marie SvaneCompleted
-
Grupo Español Multidisciplinar de MelanomaRoche Farma, S.A; Pivotal S.L.Completed
-
Adil DaudNational Comprehensive Cancer NetworkCompleted
-
Genentech, Inc.CompletedMetastatic Melanoma, BRAF V600 Mutation PositiveKorea, Republic of, Russian Federation, Israel, United States
-
Fudan UniversityUnknownMelanoma Stage IIIB-IVChina
-
University of California, San FranciscoTerminatedALK Fusion Protein Expression | Stage III Cutaneous Melanoma | Stage IIIA Cutaneous Melanoma | Stage IIIB Cutaneous Melanoma | Stage IIIC Cutaneous Melanoma | Stage IV Cutaneous Melanoma | ROS1 Fusion Positive | BRAF wt Allele | Invasive Skin Melanoma | MET Fusion Gene Positive | NRAS wt Allele | NTRK1 Fusion... and other conditionsUnited States
-
Center Eugene MarquisCompletedMalignant MelanomaFrance
-
Immunovative Therapies, Ltd.CompletedColorectal Cancer MetastaticUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaSouth Africa
-
Yale UniversityNational Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
CelgeneTerminatedNeoplasm MetastasisUnited States, Australia
-
Hoffmann-La RocheCompleted
-
Walter J. StorkusNational Cancer Institute (NCI)Completed
-
Aprea TherapeuticsJules Bordet InstituteTerminated
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Hoffmann-La RocheCompletedMelanomaUnited States, Israel, Italy, Spain, Belgium, United Kingdom, Austria, Czechia, France, Netherlands, New Zealand, Russian Federation, Australia, Canada, Croatia, Portugal, Germany, Ukraine, Switzerland, Argentina, Brazil, Ireland, N... and more
-
Novartis PharmaceuticalsCompletedCancerUnited States, Australia
-
Hoffmann-La RocheCompleted
-
M.D. Anderson Cancer CenterCompleted
-
Novartis PharmaceuticalsCompletedMelanoma and Brain MetastasesCanada, United States, Australia, France, Germany, Italy, Spain
-
MedImmune LLCCompletedMelanomaItaly, United States, Canada, France
-
University Health Network, TorontoCompleted
-
Hoffmann-La RocheCompletedStudy of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid TumorsSolid TumorsUnited States
-
Spanish Cooperative Group for the Treatment of...Roche Pharma AGCompleted
-
Novartis PharmaceuticalsCompletedCancerUnited States, Canada, Australia, France, Germany, Poland, Spain, United Kingdom, Italy
-
Manisha ShahNational Comprehensive Cancer NetworkCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
GlaxoSmithKlineTerminated
-
Duke UniversityWithdrawn
-
Universitair Ziekenhuis BrusselCompleted
-
The Netherlands Cancer InstituteUnknownMelanoma | Skin NeoplasmsNetherlands